We’re a technology company pioneering the future of bioanalysis science to unveil the invisible components of nature.
Our proprietary monolithic capillary column, "AqasPrime™", enables ultra-precise separation and visualization of trace compounds in complex natural samples.
From plants and food to pharmaceuticals and cosmetics, we empower non-targeted analysis that reveals previously unknown constituent, leading to a new value creation and breakthroughs .
Together with researchers, we’re shaping the next frontier of science.
Founded in 2023 in Kyoto via an award-winning bioanalysis platform that was developed through Japan’s AMED project. Today, we deliver that innovation in the form of our proprietary capillary column for liquid chromatography-“AqasPrime™”.
Revealing What Was Once Hidden in Nature
From flowers and trees to algae and bacteria, AqasPrime™ enables the high-resolution separation of hundreds of trace compounds simultaneously. And, turns once-invisible plant components into clear, actionable data through non-targeted analysis.
Unlocking Unknowns Across Scientific Frontiers
Beyond plants, our technology brings precision separation to a wide range of compounds—sugars, lipids, peptides, and even environmental pollutants like PFAS. It is also compatible with proteomics and metabolomics research, AqasPrime™ empowers drug discovery, food science, cosmetics, and environmental research by uncovering new insights and creating measurable value.
